Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor.
Ke-Lin
Department of Pathology, Beth Israel Hospital, Boston, Massachusetts, USA.
Qu-Hong
Nagy
J A
JA
Eckelhoefer
I A
IA
Masse
E M
EM
Dvorak
A M
AM
Dvorak
H F
HF
D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies / Q000032:analysis / Q000627:therapeutic use*; D001201:Ascites / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000276:immunology*; D004730:Endothelium, Vascular; D005260:Female; D006651:Histocytochemistry; D008222:Lymphokines / Q000276:immunology*; D008325:Mammary Neoplasms, Experimental / Q000628:therapy; D008546:Melanoma, Experimental / Q000628:therapy; D051379:Mice; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy; D011863:Radioimmunoassay; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000906:Antibodies; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors